http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111593053-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56972
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111593053-B
titleOfInvention DNA aptamer for identifying human programmed death receptor 1, method and application
abstract The invention discloses a DNA aptamer for identifying a human programmed death receptor 1, a method and application, and belongs to the field of biochemical detection. Screening aptamers by using a Cell-SELEX technology, transfecting L02 cells with the constructed pDisplay/PD-1N surface display expression plasmid, and carrying out resistance screening by using G418 to obtain a Cell line L02-PD-1N for stably expressing PD-1N. And screening by taking the L02-PD-1N cell as a target, performing repeated multiple rounds of incubation-elution-amplification by using the oligonucleotide library and the cell line, performing reverse screening by using the cell which does not express PD-1N, and finally obtaining the ssDNA (single stranded deoxyribonucleic acid), namely the aptamer, capable of binding the PD-1N with high affinity by identifying the enriched ssDNA sub-library, sequencing and comparing affinity. The invention provides a DNA aptamer for identifying human PD-1N, which takes the aptamer as a core, can utilize biotin, fluorescent markers and the like to identify PD-1 molecules on the surfaces of T lymphocytes in cells or tissues, and has potential application prospects in diagnosis and treatment of tuberculosis, tumors and the like.
priorityDate 2020-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110087731-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID60533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423536588
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18566
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29126
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56603655
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449564043
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID613842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24847876

Total number of triples: 33.